Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies

Detalles Bibliográficos
Autores principales: Kittai, Adam S., Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O., Okada, Craig, Park, Byung, Spurgeon, Stephen E., Danilov, Alexey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252925/
https://www.ncbi.nlm.nih.gov/pubmed/33504141
http://dx.doi.org/10.3324/haematol.2020.270298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252925/
https://www.ncbi.nlm.nih.gov/pubmed/33504141
http://dx.doi.org/10.3324/haematol.2020.270298

Ejemplares similares